£325.00

It has never been this cheap. We have no record of a lower price.

£325 today · cheaper than every other day in the last 3 months

DPP-IV Inhibitors in Europe 2013-2018 Econometric Study

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 33 days · 33 data points (no recent data)

Historical
Generating forecast…
£325.00 £308.75 £315.25 £321.75 £328.25 £334.75 £341.25 11 August 2026 19 August 2026 27 August 2026 04 September 2026 12 September 2026
View at Amazon ↗

Price data last checked 58 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 33 days • 1 price levels

Days at Price
33 days 0 8 17 25 33 £325 Days at Price

Price Analysis

Most common price: £325 (33 days, 100.0%)

Price range: £325 - £325

Price levels: 1 different prices over 33 days

Description

This econometric study provides a detailed outlook for dipeptidyl peptidase IV (DPP-IV) inhibitors in the European market from 2013 to 2018. By utilizing econometric models that project fundamental economic dynamics within and across countries, the report establishes latent demand estimates for each reported year. Readers gain access to Potential Industry Earnings (P.I.E.) for specific countries, expressed in millions of U.S. dollars. The data includes the percent share each country holds within the region and the global market. These comparative benchmarks allow professionals to quickly gauge a specific country's standing relative to others in the industry. This resource is designed for those needing precise economic projections and market share analysis for the DPP-IV inhibitor sector in Europe.

Key Features

Provides econometric projections for the DPP-IV inhibitor market in Europe covering the years 2013-2018.

Includes estimates for latent demand and Potential Industry Earnings (P.I.E.) in millions of U.S. dollars.

Offers comparative benchmarks by calculating the percent share of each country relative to the region and the globe.

Uses econometric models to project fundamental economic dynamics for individual countries and across the European region.

Delivered by ICON Group International, Inc. as a specialized study for business and economics professionals.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
17 July 2013
Listed Since
24 July 2013

Similar Products You Might Like

The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Japan
99% match

The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Japan

£495.00 08 Sep 2026
The 2013 Report on Dipeptidyl Peptidase IV (DPP-IV) Inhibitors: World Market Segmentation by City
98% match

The 2013 Report on Dipeptidyl Peptidase IV (DPP-IV) Inhibitors: World Market Segmentation by City

£795.00 06 Sep 2026
The 2023-2028 Outlook for Peptides and Heparin for Diabetes in Japan
96% match

The 2023-2028 Outlook for Peptides and Heparin for Diabetes in Japan

£495.00 26 Aug 2026
Peptides and Heparin for Diabetes in India Outlook 2023-2028
96% match

Peptides and Heparin for Diabetes in India Outlook 2023-2028

£515.00 03 Sep 2026
Peptides and Heparin for Diabetes Outlook 2023-2028 Study
96% match

Peptides and Heparin for Diabetes Outlook 2023-2028 Study

£520.00 28 Aug 2026
Drug Discovery Technologies Outlook 2013-2018 - Econometric Study
96% match

Drug Discovery Technologies Outlook 2013-2018 - Econometric Study

£325.00 03 Oct 2026
Peptides and Heparin for Diabetes Outlook 2023-2028 Study
96% match

Peptides and Heparin for Diabetes Outlook 2023-2028 Study

£490.00 03 Sep 2026
The 2013-2018 Outlook for Drug Discovery Technologies in North America & the Caribbean
96% match

The 2013-2018 Outlook for Drug Discovery Technologies in North America & the Caribbean

£325.00 26 Sep 2026
The 2013-2018 Outlook for Generic Drugs in India
96% match

The 2013-2018 Outlook for Generic Drugs in India

£495.00 01 Oct 2026
World Outlook for Peptides and Heparin for Diabetes 2025-2030
96% match

World Outlook for Peptides and Heparin for Diabetes 2025-2030

Price unavailable
Online Health and Pharmacy Outlook in Europe 2013-2018
96% match

Online Health and Pharmacy Outlook in Europe 2013-2018

£325.00 25 Aug 2026
India Insulin and Anti-Diabetic Hormone Market Outlook 2016-2021
96% match

India Insulin and Anti-Diabetic Hormone Market Outlook 2016-2021

£595.00 08 Sep 2026
The 2013-2018 Outlook for E-Paper Displays in Europe
96% match

The 2013-2018 Outlook for E-Paper Displays in Europe

£325.00 28 Aug 2026
US Animal Health API Outlook 2023-2028 Report
96% match

US Animal Health API Outlook 2023-2028 Report

£520.00 03 Sep 2026
Small Molecule Kinase Inhibitors Outlook in Latin America
96% match

Small Molecule Kinase Inhibitors Outlook in Latin America

£325.00 26 Aug 2026
US Insulin and Anti-Diabetic Hormone Market Outlook Study
96% match

US Insulin and Anti-Diabetic Hormone Market Outlook Study

£595.00 09 Sep 2026
Exocrine Pancreatic Insufficiency Therapeutics Outlook 2023-2028
96% match

Exocrine Pancreatic Insufficiency Therapeutics Outlook 2023-2028

£520.00 29 Aug 2026
The 2013-2018 Outlook for Synthetic Organic Medicinal Chemicals, Medicinal and Botanical Drugs and Chemicals in Bulk, Alkaloid Drugs, and Naturally Occurring Vitamins in India
96% match

The 2013-2018 Outlook for Synthetic Organic Medicinal Chemicals, Medicinal and Botanical Drugs and Chemicals in Bulk, Alkaloid Drugs, and Naturally Occurring Vitamins in India

£495.00 02 Sep 2026
The 2013-2018 Outlook for Drugs for Alzheimer's and Parkinson's Diseases in North America & the Caribbean
96% match

The 2013-2018 Outlook for Drugs for Alzheimer's and Parkinson's Diseases in North America & the Caribbean

£325.00 29 Sep 2026
The 2013-2018 Outlook for Topical Antiseptic Medications in India
96% match

The 2013-2018 Outlook for Topical Antiseptic Medications in India

£495.00 21 Sep 2026
The 2023-2028 Outlook for GLP-1 Agonists for Type 2 Diabetes in China
96% match

The 2023-2028 Outlook for GLP-1 Agonists for Type 2 Diabetes in China

£495.00 02 Sep 2026
The 2013-2018 Outlook for Drugstores in India
95% match

The 2013-2018 Outlook for Drugstores in India

£495.00 26 Sep 2026